United States · FDA National Drug Code directory
Spironolactone and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53489-144_b1902b0c-42e6-4e08-bb4a-959280f33579
- Product NDC
- 53489-144
- Form
- TABLET
- Composition / generic term
- Spironolactone and Hydrochlorothiazide
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19870702
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (53489-144-01) · 53489-144-01
- 500 TABLET in 1 BOTTLE, PLASTIC (53489-144-05) · 53489-144-05
- 1000 TABLET in 1 BOTTLE, PLASTIC (53489-144-10) · 53489-144-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →